Population-based cohort study suggesting a significantly increased risk of developing chronic obstructive pulmonary disease in people with type 2 diabetes mellitus.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  2018-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.diabres.2018.01.037PMID 29408706
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study

  2017cited by this paper
• Socioeconomic inequality in clusters of health-related behaviours in Europe: latent class analysis of a cross-sectional European survey

  2017cited by this paper
• Metabolic Syndrome as a Factor Affecting Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease.

  2017cited by this paper
• The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review

  2016cited by this paper
• IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes.

  2016cited by this paper
• Extreme Values of Hemoglobin A1c Are Associated With Increased Risks of Chronic Obstructive Pulmonary Disease in Patients With Type 2 Diabetes

  2015cited by this paper
• Comorbidity between chronic obstructive pulmonary disease and type 2 diabetes: A nation-wide cohort twin study.

  2015cited by this paper
• Does Improving Exercise Capacity and Daily Activity Represent the Holistic Perspective of a New COPD Approach?

  2015cited by this paper
• The costs of smoking and secondhand smoke exposure in Taiwan: a prevalence-based annual cost approach

  2014cited by this paper
• Pulmonary Function Reduction in Diabetes With and Without Chronic Obstructive Pulmonary Disease

  2014cited by this paper
• Chronic obstructive pulmonary disease: a risk factor for type 2 diabetes: a nationwide population‐based study

  2013cited by this paper
• Pulmonary function tests in type 2 diabetics and non-diabetic people -a comparative study.

  2013cited by this paper
• Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony

  2012cited by this paper
• Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids.

  2012cited by this paper
• Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease.

  2012cited by this paper
• Type II diabetes mellitus is associated with decreased measures of lung function in a clinical setting.

  2011cited by this paper
• Pulmonary function in diabetes: a metaanalysis.

  2010cited by this paper
• Inadequate glucose control in type 2 diabetes is associated with impaired lung function and systemic inflammation: a cross-sectional study

  2010cited by this paper
• Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts.

  2010cited by this paper
• Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications

  2010cited by this paper
• Glucose homeostasis across human airway epithelial cell monolayers: role of diffusion, transport and metabolism

  2009cited by this paper
• Patients Diagnosed With Diabetes Are at Increased Risk for Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Fibrosis, and Pneumonia but Not Lung Cancer

  2009cited by this paper
• Blood glucose: of emerging importance in COPD exacerbations

  2009cited by this paper
• Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease

  2008cited by this paper
• Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD

  2008cited by this paper
• Cross-Sectional and Prospective Study of Lung Function in Adults With Type 2 Diabetes

  2008cited by this paper
• Attenuated Superoxide Dismutase Induction in Retinal Cells in Response to Intermittent High Versus Continuous High Glucose

  2007cited by this paper
• Beyond Comorbidity Counts: How Do Comorbidity Type and Severity Influence Diabetes Patients’ Treatment Priorities and Self-Management?

  2007cited by this paper
• Neurological Disorders: Public Health Challenges

  2007cited by this paper
• Age and Sex May Significantly Interact With Diabetes on the Risks of Lower-Extremity Amputation and Peripheral Revascularization Procedures

  2006cited by this paper
• Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction

  2006cited by this paper
• Accessibility assessment of the Health Care Improvement Program in rural Taiwan.

  2005cited by this paper
• Lung dysfunction in diabetes.

  2003cited by this paper
• Mortality in a large population-based cohort of patients with drug-treated diabetes mellitus.

  1998cited by this paper
• NIDDM, Impaired Glucose Tolerance, and Pulmonary Function in Older Adults: The Rancho Bernardo Study

  1996cited by this paper
• Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status.

  1993cited by this paper

• Exploratory Bivariate Genome-Wide Analysis in Northern Chinese Twins Suggests Potential Loci at 2q33.1 Harboring SPATS2L for Lung Function and Fasting Plasma Glucose

  2026cites this paper
• Mendelian randomization analysis of the causal relationship between COPD and type 1 and type 2 diabetes mellitus

  2025cites this paper
• Effects of complications associated with chronic obstructive pulmonary disease on lung function and hospitalization expenses: A retrospective study

  2025cites this paper
• Causal relationship between type 2 diabetes and common respiratory system diseases: a two-sample Mendelian randomization analysis

  2024cites this paper
• Integrating bioinformatics and machine learning to unravel shared mechanisms and biomarkers in chronic obstructive pulmonary disease and type 2 diabetes.

  2024cites this paper
• Research Progress on the Effect of Hypoglycemic Drugs on Diabetes Complicated with Chronic Obstructive Pulmonary Disease

  2023cites this paper
• The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease

  2023cites this paper
• TCM as adjunctive therapy improves risks of respiratory hospitalizations in persons with type 2 diabetes: A retrospective cohort study

  2023cites this paper
• Associations of diabetes, prediabetes and diabetes duration with the risk of chronic obstructive pulmonary disease: A prospective UK Biobank study

  2023cites this paper
• Metabolic syndrome, genetic susceptibility, and risk of chronic obstructive pulmonary disease: The UK Biobank Study

  2023cites this paper
• Hyperglycaemia and Chronic Obstructive Pulmonary Disease

  2023cites this paper
• Significantly increased risk of chronic obstructive pulmonary disease amongst adults with predominantly mild congenital heart disease

  2022cites this paper
• Therapeutic Approaches Targeting Molecular Signaling Pathways Common to Diabetes and Lung Diseases and Cancer.

  2021cites this paper
• Use of GLP1RAs and occurrence of respiratory disorders: A meta‐analysis of large randomized trials of GLP1RAs

  2021cites this paper
• Analysis of prevalence and prognosis of type 2 diabetes mellitus in patients with acute exacerbation of COPD

  2021cites this paper
• Clinical significance of high‐mobility group box‐1 (HMGB1) in subjects with type 2 diabetes mellitus (T2DM) combined with chronic obstructive pulmonary disease (COPD)

  2019cites this paper
• Diabetes Mellitus and Chronic Obstructive Pulmonary Disease: An Overview

  2019cites this paper
• Association between ankylosing spondylitis and chronic obstructive pulmonary disease in Taiwan.

  2018cites this paper